in

Many New mRNA Applications (Audio)

bloomberg-businessweek-01
To listen to this podcast episode, click on the Play button in the bar at the bottom of the screen. To listen while browsing, click on the Expand button at the bottom right to launch the player in a new browser tab/window.

 “Many New mRNA Applications.” This story, by Robert Langreth for Bloomberg Businessweek, explains how Moderna plans to use its mRNA technology to develop shots for influenza, HIV, Zika—and maybe even cancer.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

bloomberg-businessweek-01

U.S. Remains a Dangerous Place for Unvaccinated

the-journal-01

The Man Behind Biden's Push for More Competition